Cargando…
Incretin-based therapies in 2021 – Current status and perspectives for the future
Autores principales: | Rizzo, Manfredi, Nauck, Michael A., Mantzoros, Christos S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321622/ https://www.ncbi.nlm.nih.gov/pubmed/34333000 http://dx.doi.org/10.1016/j.metabol.2021.154843 |
Ejemplares similares
-
Novel extrapancreatic effects of incretin
por: Yamada, Yuichiro, et al.
Publicado: (2016) -
β‐Cell glutamate signaling: Its role in incretin‐induced insulin secretion
por: Yokoi, Norihide, et al.
Publicado: (2016) -
Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives
por: Seino, Yutaka, et al.
Publicado: (2016) -
Antibiotic therapy of pneumonia in the obese patient: dosing and delivery
por: Al-Dorzi, Hasan M., et al.
Publicado: (2013) -
Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2021)